Articles On Creso Pharma (ASX:CPH)

One area of the market that was smoked in October was the cannabis industry. Investors betting on the many cannabis shares listed on the local share market were nursing sizeable declines last month. Here’s what happened: The Althea Group H...

It’s been a year of highs and lows for cannabis shares. Marijuana shares were favourites of investors earlier this year but have since suffered setbacks: the vaping crisis in the United States (US) as well as issues on the home front have...

In order to boost their returns, investors usually tend to search for stocks of the companies that are likely to report relatively higher revenues and earnings in the future. The stocks that are expected to grow substantially above the aver...

In order to boost their returns, investors usually tend to search for stocks of the companies that are likely to report relatively higher revenues and earnings in the future. The stocks that are expected to grow substantially above the aver...

Althea Group Holdings Ltd (ASX:AGH) shares are in a trading halt pending an announcement, with rumours swirling that major shareholder and supplier Aphria is looking to sell their stake in the Australia marijuana supplier. Althea shares ha...

Listed cannabis stocks worldwide have pulled back from their highs lately, tainted by the vaping crisis in the US. Canopy Growth has seen its share price drift down to just above US$20 from highs of over US$50 in April. Rival Aurora Cannab...

Health stocks are reckoned amid those that can rapidly grow from a single line of product with small market capitalisation to a company worth over billions. Regarded as one of the most exciting sectors of the stock market, health stocks hol...

Small cap stocks are the stocks of those enterprises that have a low market capitalisation. Estimated market capitalisation of small cap companies is between $300 million and $2 billion. Small cap stocks have several advantages such as the...

In the few short years since cannabis companies first floated on stock exchanges around the world, they have developed a reputation for being volatile and high risk. At the start, stocks exploded in value, peaking around the start of 2018....

For a while there, it seemed like the Australian cannabis sector had stalled. Not only were many cannabis companies in limbo thanks to a large backlog of licensing applications, but all the exciting mergers and acquisitions in the industry...

After several months of waiting, THC (ASX:THC) has finally received narcotics licenses for its Southport and Bundaberg facilities. The Queensland Department of health granted THC Schedule 8 and Schedule 4 manufacturing licenses for both fac...

Government bodies across the globe are legalising the manufacturing and consumption of medical cannabis products, resulting in vast opportunities for investors. In 2018, Canada became the second largest country in the world to legalise cann...

It certainly has been a disappointing day of trade for a number of ASX cannabis shares. Three of them have just tumbled to 52-week lows or worse. Here’s why they are down in the dumps: The AusCann Group Holdings Ltd (ASX: AC8) share price h...

2018 witnessed several catalysts for the legal cannabis industry, with countries legalising medicinal cannabis, public and private sector getting into constructive discussions about the calibre and cons of the pot industry from a business p...

Cannabis industry is composed of ancillary products and services, legal cultivators and producers, consumers, researchers, independent industrial standard bodies and regulators. Lately, several companies are getting inclined towards the can...

In afternoon trade the S&P/ASX 200 index is on course to bounce back from yesterday’s selloff and finish the week on a positive note. At the time of writing the benchmark index is up 0.25% to 6,508.9 points. Four shares that have faile...

It has been a busy day in the Australian cannabis industry with a series of an announcements being made this morning. Here’s what has been happening today: BOD Australia Ltd (ASX: BDA) This morning this medicinal cannabis healthcare produc...

The Creso Pharma Ltd (ASX: CPH) share price won’t be going anywhere today and will remain suspended following the release of the cannabis company’s takeover update. What has happened? In June of this year Canadian cannabis company PharmaCi...

This week, the 33 cannabis (and cannabis-adjacent) stocks tracked by Stockhead posted an average weekly return of 3 per cent. That’s against a broader downtrend for the sector, with the BI Global Cannabis Competitive Peers index down 40 per...

The Creso Pharma Ltd (ASX: CPH) share price has pushed higher this morning after the release of a positive announcement out of the cannabis company. In morning trade the Creso Pharma share price is up almost 3% to 37.5 cents. What did Cres...

With its stock market welcoming investors from across the globe, driven by the rapid domestic acceptance on cannabinoid-based medicines, Australia has proven to be a lucrative hub for the flourishing global cannabis industry, with it being...

Cannabis was once synonymous with drugs, marijuana, ill-health and the scourges of our society. Presently, cannabis is associated with medication, business and legalisation. This proves that we have come a long way in the cannabis space, an...

With growing focus of governments across the globe on legalising recreational and medicinal cannabis, the cannabis industry is booming at a rapid pace and is expected to offer opportunities for investors. In 2016, Australia became the fourt...

South America is notorious for being home to some of the biggest illegal drug cartels in the world. I mean, who hasn’t heard of big time Colombian drug lord Pablo Escobar? (He’s even got his own Netflix series). Some of the reasons South Am...

The increasing use of medical cannabis products has prompted many countries to soften the regulations regarding the manufacturing and consumption of cannabis products. Last year, Canada became the second and the largest country in the world...

‘Pot stocks’ were making headlines in 2018. California, one of the world’s biggest economies and the most populous state in the US, finally enacted legislation to legalise the recreational use of cannabis. It joined a growing list of US st...

Special Report: PharmaCielo, the Canadian-listed medicinal cannabis company in the process of acquiring Creso Pharma, has sent its first commercial export of high-quality CBD isolate from Colombia to Europe. The export from PharmaCielo, the...

The healthcare industry of Australia is a key contributor in developing the economy. The companies who are in this industry, have to update them with the new medicine for the treatment of the diseases. The healthcare space of Australia is p...

The legalisation of medical cannabis in southeast Asia is gathering steam with news that Thailand has officially started distributing cannabis oil to eligible patients over the past week. Advocates hope that the move is a sign of things to...

Industrial hemp, commonly referred as hemp, is a strain of a plant, which is known as Cannabis Sativa. The plant, which is cultivated for the industrial usage, is amongst the fastest growing plants. In the month of November 2017, industrial...

The MGC Pharmaceuticals Ltd (ASX: MXC) share price could be on the move today after the cannabis company released a late announcement on Thursday. What did MGC Pharmaceuticals announce? On Thursday MGC Pharmaceuticals provided an update on...

Australia has established its strong position in the contemporary world that is welcoming the good side of cannabis with open arms, amid the recreational legalising debates. The country joined the bandwagon of Alaska, Canada, North Korea an...

The federal government has taken steps to cut red tape and speed up the granting of licences for Australia’s cannabis players. Health Minister Greg Hunt said the federal government would boost the nation’s medicinal cannabis industry by pri...

Legalisation of Cannabis in Australia Cannabis is widely used for the remedies of Palliative care, Chronic non-cancer pain, Nausea and vomiting, Multiple sclerosis and many more chronic diseases. Before 2016, the production of cannabis was...

Medicinal cannabis manufacturer and developer Creso Pharma (ASX: CPH) has signed a key deal with New Zealand's Medleaf Therapeutics. The deal will see Australia-listed Creso push deeper into the bourgeoning medicinal cannabis market acros...

Medicinal cannabis manufacturer and developer Creso Pharma (ASX: CPH) has signed a key deal with New Zealand's Medleaf Therapeutics. The deal will see Australia-listed Creso push deeper into the bourgeoning medicinal cannabis market acros...

Special Report: Barely a day is going by without positive news out of medicinal cannabis innovator Creso Pharma, with the company signing an exclusive distribution deal for its CBD products in New Zealand. Creso (ASX:CPH) is flexing its mus...

The Creso Pharma Ltd (ASX: CPH) share price could be on the rise this morning after the cannabis company released a positive update. What did Creso Pharma announce? This morning Creso Pharma announced the signing of a comprehensive distrib...

The Medlab Clinical Ltd (ASX: MDC) share price rose 7.7% to a 52-week high of $0.56 in early Monday trade, although it has since dropped back slightly to $0.51 per share at the time of writing. The strong start to the trading week occurred...

Special Report: Creso Pharma has received the first orders for its innovative therapeutic lozenges from one of Australia’s leading medicinal cannabis companies. It’s the latest big development for Creso Pharma (ASX:CPH), which has been on a...

Special Report: Revenue for the six months to June rose by over 400 per cent to nearly $1 million for Creso Pharma, ahead of its acquisition by PharmaCielo. Revenue of $926,675 — compared with only $184,076 in prior corresponding period — w...

In 2016, Australia legalised cannabis for medicinal and scientific purposes under the Narcotic Drugs Amendment Act 2016. The amendment provided relief to the cannabis sector and enabled the prospective producers to apply for the necessary l...

Is the world progressing at a pace that it would “go green” when it comes to legalizing of cannabis? The controversy that this topic of taboo holds for the globe is paramount and never-ending; but lately, there has been paradigm shift and a...

Sponsored Content Creso Pharma (ASX:CPH) is set to quadruple its global footprint as it’s acquired by Canadian cannabis company PharmaCielo. And that move is now a step closer, thanks to Creso paying down $5.2 million of its debt, satisfyin...

Wth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis industry has boomed quite a bit in recent times. Let’s take a quick look at 20 cannabis companies trading on ASX. Cann Group Limited (ASX:...

The cannabis market is expected to grow multi-fold in the next decade, given the legalisation of Cannabis around the world for its medicinal properties and recreational purposes. Three important pot stocks are Zelda Therapeutics Limited, Cr...

CBD may not yet be approved for sale in Australian stores but this doesn't mean Australian listed companies aren't pursuing the offshore market opportunity where regulations have paved a path for this growing industry. Elixinol Global Limit...

The ASX’s 32 tradeable pot stocks and pot stock wannabees are down 17 per cent over the last 12 months. The Small Ords (ASX:XSO) has risen 1.62 per cent in the same time, and the All Ords (ASX:XAO) and the ASX200 (ASX:XJO) are both up over...

Do you know that market enthusiasts believe that legalising cannabis would generate approximately $8.5 billion in the country’s federal and state tax? Ponder over the massive revenue that this sector would add to the necessities related to...

The Medlab Clinical Ltd (ASX: MDC) share price is up 7.1% to $0.38 in Thursday trade following the release of an operations update this morning. The company announced that it had delivered a very strong June quarter, with progress being ma...